Market Overview

BCMA -Targeted Antibodies & T-Cells in: October 2016 R&D and Business Tracker for TCR & CAR T-Cells and NK Cells - Research and Markets

Share:
DUBLIN--(BUSINESS WIRE)--

Research and Markets has announced the addition of the "BCMA -Targeted Antibodies & T-Cells in: October 2016 R&D and Business Tracker for TCR & CAR T-Cells and NK Cells" report to their offering.

BCMA-Targeted Antibodies & T-Cells in: October 2016 R&D and Business Tracker for TCR & CAR T-Cells and NK Cells

This pdf report contains information about TCR & CAR engineered T-cells and NK cells released during the month of October 2016. This issue forms part of the subscription service R&D and Business Tracker for TCR & CAR T-Cells and NK Cells

Featured presentations of October 2016 include the pipeline of B-Cell Maturation Antigen (BCMA)-targeted antibodies & T-cells, the profile of US biotech Poseida Therapeutics and the profile of anti-BCMA CARtyrin T-cell product candidate P-BCMA-101 from Poseida Therapeutics.

The October 2016 issue of the author's R&D and Business Tracker service about TCR & CAR engineered T-cells and NK cells contains:

R&D and Technology Tracker

- Pipeline changes

- Regulatory news

- Technology validations

Business Tracker for:

- Company updates

- Collaboration

- Licensing

- Merger & acquisitions

- Financing

Clinical Trial Tracker

Scientific Publication Tracker

Featured Cell Therapy Profile: P-BCMA-101 Featured Company Profile: Poseida Therapuetics

Featured Target or Technology Pipeline: BCMA-Targeted Antibodies & T-Cells

BCMA-Targeted Antibodies & T-Cells include:

- Autologous & allogeneic T-Cells

- Bispecific tumor-targeted antibodies & T-cells

- Bispecific T-Cell and NK-Cell redirecting antibodies

- Antibody-Drug Conjugates

Information about the BCMA-Targeted Antibodies & T-Cells pipeline is provided in a tabular format and fully referenced.

For more information about this report visit http://www.researchandmarkets.com/research/4hgkq5/bcma_targeted

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Immune Disorders Drugs, Oncology Drugs

View Comments and Join the Discussion!
 

Partner Center